Escolar Documentos
Profissional Documentos
Cultura Documentos
)
DOI: 10.4197 / Eng. 22-1.1
1. Introduction
Of the mineral phase of bone. It consists of 70% limits, so that it will be
responsible For the advancement of science and technology in the
development of high-impact materials, ceramic products, especially those
used in medical, veterinary, pharmaceutical and biological applications
invented, and used in the construction of the living body in order to
repair or replace the defective parts after cultivation in compensation for
the damaged fabric [1].
3
4 Waleed A. Hanna, et al.
2. Experimental Part
Table 3 presents the chemical composition of glass powder, in the
system (Na2O-CaO-SiO2-P2O5) that is used in this study as a raw material
for the preparation of sintered samples and sizing of Glass powders to (<
53) microns were done. The physical characteristics of the powder are
listed in Table 4.
The Effect of 5 wt %Yettria-Stabilized Zirconia on Crystallized… 7
Data Characteristics
3
20.831gm/cm Theoretical density
Oxides Wt. %
Y2O3 5.4
SiO2 0.11
TiO2 0.12
Al2O3 0.25
Fe2O3 0.003
Na2O 0.02
CaO 0.05
Temperature (oC)
Temperature (oC)
Temperatures[oC]
800 900 1000 1100
CaSiO3 CaSiO3 CaSiO3 CaSiO3
Ca2SiO4 Ca2P2O7 ZrO2 Ca2SiO4
Ca2P2O7
ZrSiO4 Ca2SiO4
Na2HPO4
The Effect of 5 wt %Yettria-Stabilized Zirconia on Crystallized… 13
At the end of the fourth week, the defective bone cavity was almost
closed without the appearance of any inflammatory or signs of rejection
of tissue around the implantation area. The size of the form is invariably
almost (14.5 × 8) mm, with a wavy surface because of absorption
process. The matter of implanted sample and transformation of the dark
appearance of the implant, due to absorption, with clear channel began to
show the bone marrow, as shown in Fig. 4 (c).
Fig. 4. Radiograph X- ray pictures of the Implanted sample in a Tibia: A-after operation.
B-after Two weeks. C- after fourth weeks.
14 Waleed A. Hanna, et al.
4. Conclusions
a - Temperature of crystallization (800 & 1100) are favorites to
reach high hardness and fracture toughness when (5) wt% of (ZrO2.Y2O3)
is added.
b - Adding (5)wt% of (ZrO2.Y2O3) phases which consist of Ca.
root such as the strong phases of bioactivity CaSiO3 and Ca2P2O7,
helps and accelerates the healing process of the bone.
c - Implantation of sintered glass ceramic containing
(5)wt%(ZrO2.Y2O3) in the Tibia bone of a dog, for one month did not
show any signs of infection at the implantation site and nontoxic
substance release with a building bridge of the defected bone.
5. References
[1] Al-Nasir, Waleed Asim, “Study the Effect of TiO2 Addition on Some of the Physical and
Mechanical Properties of (Na2O – CaO – SiO2 – P2O5) System”, Ph.D, University of
Technology, Iraq, (2002).
[2] Thikra Hamdi Ali, “Study the effect of variables manufacturing process on the fracture
toughness and the fracture strength of ceramic materials”, MA, University of Technology,
Iraq, in October, (1999).
[3] Waleed Hanna, S. M. Al-Saffar, “Effect of recrystalization temperature and ZrO2-Y2O3
addition on some of physical and mechanical properties of (Na2O-CaO-SiO2-P2O5)”,
Jordanian International Conference of Materials Science and Engineering, (MSE2) 4-6-2007.
[4] Toshihiro Kasuga, “Preparation of Zirconium – Toughened Bioactive Glass – Ceramics”;
Journal of Materials Science, Vol. (23), No. (6), June, PP (2255), (1988).
[5] Hermansson J. Ti, L, “Mechanical Evaluation of Hot Isostatic Pressed Hydroxy – Apatite”,
Inter. ceramic., Vol. (39), No. (2), April. (1990).
[6] Carlos Laveruia, “Calcium Phosphate Ceramics as bone Substitutes”, Ceramic Bulletin,
Vol. (70), No. (1). (1991).
[7] Shigeyuki Somiya, “Advanced Technical ceramics”, 1988.
[8] Williams, “The Science and Applications of Biomaterials”, Advanced in Materials
Technology Monitor, Vol. (1), No.(2), University of Liverpool, UK. (1994).
[9] Joyce Y .Wong and Joseph D. Bronzino, (Biomaterials) CRC press: Taylor & Francis
group, Boca Raton, London, New York, 2007.
[10] Paulo Bartolo and Bopaya Bidanda, “Bio-Materials Prototyping applications in
Medicine”, Springer science + Business Media, New York, USA 2008.
[11] Larry L. Hench, Bioceramics from concept to clinic, J. Am. Ceram. Soc., Vol. (74), No. (7),
1991.
[12] Internet; “Clinical Applications of Biogases and Bioactive glass Ceramic”. Source:
Abstracted form; Innovative Bioceramics. In Materials forum Vol. 27 PP (4). (2004)
.G.Heness and Ben-Nissan.
[13] Van Noort R. Black M. M., “Development in the Biomedical Evaluation of Silicone
Rubber”, Journal of Materials Science, Vol. (14),NO.(1) .PP(197-204) , Dep. of Medical
Physics, University of Sheffield.UK. (1979).
[14] Yurig.Bushuer V.. Karpov N and Yuri G. SHapo Shnikov, “New Materials in Medicine”,
(1992).
The Effect of 5 wt %Yettria-Stabilized Zirconia on Crystallized… 15
–
.
– #
"(5) !
?78> 5
< 1
%7 4=
9
.'
1A9 + &8
B &
@
A
:
%
C + 5'
D *
E
; 6
&78
5 D !
.
&
'
F G
.4<
7 N 8I 12 + . (ZrO2.Y2O3)
L
IH + *4
G *7 O' 1
&
– #
6'
6J'
;
:
.
6
6+